Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Whole Blood Versus Fractionated Blood Products in Acute Traumatic Hemorrhage
NCT04431999Phase 3Completed
- Sponsor
- French Defence Health Service
- Start
- Dec 2021
- Primary completion
- Oct 2025
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 3, randomised trial of low-titer group O whole blood in traumatic hemorrhage and coagulopathy (2 arms), sponsored by French Defence Health Service. Primary endpoint: Non inferiority on the correction of coagulopathy at 6 hours. Started Dec 2021; status: completed.
02
Drugs
low-titer group O whole blood
03
Conditions
traumatic hemorrhagecoagulopathy
Beyond the preview
Go deeper on NCT04431999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04431999.